456 related articles for article (PubMed ID: 19852747)
1. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
Pincus T
Bull NYU Hosp Jt Dis; 2009; 67(3):254-66. PubMed ID: 19852747
[TBL] [Abstract][Full Text] [Related]
2. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.
Pincus T; Yazici Y; Bergman MJ
Rheum Dis Clin North Am; 2009 Nov; 35(4):773-8, viii. PubMed ID: 19962621
[TBL] [Abstract][Full Text] [Related]
3. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
Yazici Y; Bergman M; Pincus T
J Rheumatol; 2008 Apr; 35(4):603-9. PubMed ID: 18322993
[TBL] [Abstract][Full Text] [Related]
4. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.
Pincus T; Swearingen CJ; Bergman MJ; Colglazier CL; Kaell AT; Kunath AM; Siegel EL; Yazici Y
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):181-9. PubMed ID: 20191516
[TBL] [Abstract][Full Text] [Related]
5. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
Pincus T; Swearingen CJ; Bergman M; Yazici Y
J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
[TBL] [Abstract][Full Text] [Related]
6. RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol.
Pincus T; Furer V; Keystone E; Yazici Y; Bergman MJ; Luijtens K
Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1142-9. PubMed ID: 21485024
[TBL] [Abstract][Full Text] [Related]
7. A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ).
Pincus T; Yazici Y; Bergman M; Maclean R; Harrington T
Best Pract Res Clin Rheumatol; 2007 Aug; 21(4):789-804. PubMed ID: 17678835
[TBL] [Abstract][Full Text] [Related]
8. Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care.
Pincus T; Yazici Y; Castrejón I
Bull NYU Hosp Jt Dis; 2012; 70 Suppl 1():30-6. PubMed ID: 23259656
[TBL] [Abstract][Full Text] [Related]
9. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
Castrejón I; Dougados M; Combe B; Guillemin F; Fautrel B; Pincus T
J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
[TBL] [Abstract][Full Text] [Related]
10. Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials.
Pincus T; Hines P; Bergman MJ; Yazici Y; Rosenblatt LC; MacLean R
J Rheumatol; 2011 Dec; 38(12):2565-71. PubMed ID: 22089467
[TBL] [Abstract][Full Text] [Related]
11. RAPID3-an index of physical function, pain, and global status as "vital signs" to improve care for people with chronic rheumatic diseases.
Pincus T; Bergman MJ; Yazici Y
Bull NYU Hosp Jt Dis; 2009; 67(2):211-25. PubMed ID: 19583557
[TBL] [Abstract][Full Text] [Related]
12. Are patient questionnaire scores as "scientific" as laboratory tests for rheumatology clinical care?
Pincus T
Bull NYU Hosp Jt Dis; 2010; 68(2):130-9. PubMed ID: 20632989
[TBL] [Abstract][Full Text] [Related]
13. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis.
Ringold S; Chon Y; Singer NG
Arthritis Rheum; 2009 Dec; 60(12):3776-83. PubMed ID: 19950286
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
Singh H; Gupta V; Ray S; Kumar H; Talapatra P; Kaur M; Kumar S; Arya S; Mathur R; Ghangas N
Clin Rheumatol; 2012 Dec; 31(12):1663-9. PubMed ID: 22983768
[TBL] [Abstract][Full Text] [Related]
15. An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician report.
Pincus T; Castrejón I
Bull NYU Hosp Jt Dis; 2012; 70(2):73-94. PubMed ID: 22891997
[TBL] [Abstract][Full Text] [Related]
16. Pain, function, and RAPID scores: vital signs in chronic diseases, analogous to pulse and temperature in acute diseases and blood pressure and cholesterol in long-term health.
Pincus T
Bull NYU Hosp Jt Dis; 2008; 66(2):155-65. PubMed ID: 18537789
[TBL] [Abstract][Full Text] [Related]
17. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.
Pincus T; Bergman MJ; Yazici Y; Hines P; Raghupathi K; Maclean R
Rheumatology (Oxford); 2008 Mar; 47(3):345-9. PubMed ID: 18238788
[TBL] [Abstract][Full Text] [Related]
18. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries.
Sokka T; Hetland ML; Mäkinen H; Kautiainen H; Hørslev-Petersen K; Luukkainen RK; Combe B; Badsha H; Drosos AA; Devlin J; Ferraccioli G; Morelli A; Hoekstra M; Majdan M; Sadkiewicz S; Belmonte M; Holmqvist AC; Choy E; Burmester GR; Tunc R; Dimić A; Nedović J; Stanković A; Bergman M; Toloza S; Pincus T;
Arthritis Rheum; 2008 Sep; 58(9):2642-51. PubMed ID: 18759292
[TBL] [Abstract][Full Text] [Related]
19. Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAI.
Yokogawa N; Kaneko T; Nagai Y; Nunokawa T; Sawaki T; Shiroto K; Shimada K; Sugii S
Mod Rheumatol; 2015 Mar; 25(2):264-9. PubMed ID: 25156777
[TBL] [Abstract][Full Text] [Related]
20. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
Linde L; Sørensen J; Østergaard M; Hørslev-Petersen K; Hetland ML
J Rheumatol; 2010 Feb; 37(2):285-90. PubMed ID: 20080905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
